Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Human Gene Therapy|April 14, 2006
Effect of serotype 5 adenoviral and serotype 2 adeno- associated viral vector-mediated gene transfer to salivary glands on the composition of salivaJianghua Wang, Antonis Voutetakis, Fumi Mineshiba, et al.
Arthritis and Rheumatism|March 13, 2003
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritisDimitrios T Boumpas, Richard Furie, Susan Manzi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 28, 2015
Predominant Glandular Cholinergic Dysautonomia in Patients With Primary Sjögren's SyndromeRichard Imrich, Ilias Alevizos, Lolita Bebris, et al.
Cellular and Molecular Neurobiology|February 22, 2012
Adrenomedullary response to glucagon in patients with primary Sjögren's syndromeRichard Imrich, Nikolay P Nikolov, Lolita Bebris, et al.
The Journal of Clinical Investigation|November 18, 2003
Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactionsAmrie C Grammer, Rebecca Slota, Randy Fischer, et al.
Arthritis and Rheumatism|July 13, 2004
Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritisKazuki Takada, Million Arefayene, Zeruesenay Desta, et al.
Annals of the Rheumatic Diseases|March 25, 2016
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled studyMunther Khamashta, Joan T Merrill, Victoria P Werth, et al.
Arthritis and Rheumatism|June 28, 2006
Abnormal differentiation of memory T cells in systemic lupus erythematosusRuth D Fritsch, Xinglei Shen, Gabor G Illei, et al.
Immunity|November 6, 2012
Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritisPrapaporn Pisitkun, Hye-Lin Ha, Hongshan Wang, et al.
Arthritis and Rheumatism|January 30, 2010
Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation studyGabor G Illei, Yuko Shirota, Cheryl H Yarboro, et al.
Pageof 6